The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure

Cancer Prevention Research

Volumn 6, Issue 12, 2013, Pages 1262-1272

  Szpunar, Mercedes J ^a   Burke, Kathleen A ^a   Dawes, Ryan P ^a   Brown, Edward B ^a   Madden, Kelley S ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; DESIPRAMINE; DEXMEDETOMIDINE; FIBRILLAR COLLAGEN; INTERLEUKIN 6; ISOPRENALINE; PHENYLEPHRINE; RANTES; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER TRANSPLANTATION; COLLAGEN DEFECT; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; TUMOR GROWTH;

ADENOCARCINOMA; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; COLLAGEN; CYTOKINES; DESIPRAMINE; DEXMEDETOMIDINE; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-2; TUMOR CELLS, CULTURED;

EID: 84890470662     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0079     Document Type: Article

References (45)

1. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617-25.
2. Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK. Neuroendocrine modulation of cancer progression. Brain Behav Immun 2009;23:10-5.
3. Cole SW, Sood AK. Molecular pathways: β-adrenergic signaling in cancer. Clin Cancer Res 2012;18:1201-6.
4. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006;6:240-8.
5. Lutgendorf SK, Sood AK. Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Psychosom Med 2011;73:724-30.
6. Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, et al. Autonomic nerve development contributes to prostate cancer progression. Science 2013;341:1236361.
7. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006;12:939-44.
8. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 2010;70:7042-52.
9. Campbell JP, Karolak MR, Ma Y, Perrien DS, Masood-Campbell SK, Penner NL, et al. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol 2012;10:e1001363.
10. Powe DG, Voss MJ, Habashy HO, Zanker KS, Green AR, Ellis IO, et al. α- and β-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study. Breast Cancer Res Treat 2011;130:457-63.
11. Madden KS, Szpunar MJ, Brown EB. β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines. Breast Cancer Res Treat 2011;130:747-58.
12. Vandewalle B, Revillion F, Lefebvre J. Functional β-adrenergic receptors in breast cancer cells. J Cancer Res Clin Oncol 1990;116:303-6.
13. Bruzzone A, Pinero CP, Rojas P, Romanato M, Gass H, Lanari C, et al. α(2)-Adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells. Curr Cancer Drug Targets 2011;11:763-74.
14. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 2007;21:736-45.
15. Moreaux L, Sandre O, Charpak S, Blanchard-Desce M, Mertz J. Coherent scattering in multi-harmonic light microscopy. Biophys J 2001;80:1568-74.
16. Sidani M, Wyckoff J, Xue C, Segall JE, Condeelis J. Probing the microenvironment of mammary tumors using multiphoton microscopy. J Mammary Gland Biol Neoplasia 2006;11:151-63.
17. Wang W, Wyckoff JB, Frohlich VC, Oleynikov Y, Huttelmaier S, Zavadil J, et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res 2002;62:6278-88.
18. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003;3:921-30.
19. Burke K, Tang P, Brown E. Second harmonic generation reveals matrix alterations during breast tumor progression. J Biomed Opt 2013;18:31106.
20. Kakkad SM, Solaiyappan M, Argani P, Sukumar S, Jacobs LK, Leibfritz D, et al. Collagen I fiber density increases in lymph node positive breast cancers: pilot study. J Biomed Opt 2012;17:116017.
21. Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 2011;178:1221-32.
22. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992;52:1399-405.
23. Schildkraut JJ, Dodge GA, Logue MA. Effects of tricyclic antidepressants on the uptake and metabolism of intracisternally administered norepinephrine-H3 in rat brain. J Psychiatr Res 1969;7:29 -34.
24. Glowinski J, Axelrod J. Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 1964;204:1318-9.
25. Marjamaki A, Ala-Uotila S, Luomala K, Perala M, Jansson C, Jalkanen M, et al. Stable expression of recombinant human α2-adrenoceptor subtypes in two mammalian cell lines: characterization with [3H]rauwolscine binding, inhibition of adenylate cyclase and RNase protection assay. Biochim Biophys Acta 1992;1134:169-77.
26. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 2004;56:331-49.
27. Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 2010;22:697-706.
28. Burke RM, Madden KS, Perry SW, Zettel ML, Brown EB. Tumor-associated macrophages andstromal TNF-alpha regulate collagenstructure in breast tumor models as visualize by second harmonic generation. J Biomed Opt 2013;18:86003.
29. Bruzzone A, Pinero CP, Castillo LF, Sarappa MG, Rojas P, Lanari C, et al. α2-Adrenoceptor action on cell proliferation and mammary tumour growth in mice. Br J Pharmacol 2008;155:494-504.
30. Vazquez SM, Mladovan AG, Perez C, Bruzzone A, Baldi A, Luthy IA. Human breast cell lines exhibit functional α2-adrenoceptors. Cancer Chemother Pharmacol 2006;58:50-61.
31. Khan ZP, Ferguson CN, Jones RM. α2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999;54:146-65.
32. Piletz JE, Zhu H, Chikkala DN. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of α2 adrenoceptor subtypes. J Pharmacol Exp Ther 1996;279:694-702.
33. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008;14:518-27.
34. DuPre SA, Hunter KW Jr. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol 2007;82:12-24.
35. Han X, Burke RM, Zettel ML, Tang P, Brown EB. Second harmonic properties of tumor collagen: determining the structural relationship between reactive stroma and healthy stroma. Opt Express 2008;16:1846-59.
36. Williams RM, Zipfel WR, Webb WW. Interpreting second-harmonic generation images of collagen I fibrils. Biophys J 2005;88:1377-86.
37. Lacomb R, Nadiarnykh O, Townsend SS, Campagnola PJ. Phase matching considerations in second harmonic generation from tissues: effects on emission directionality, conversion efficiency and observed morphology. Opt Commun 2008;281:1823-32.
38. Diop-Frimpong B, Chauhan VP, Krane S, Boucher Y, Jain RK. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci U S A 2011;108:2909-14.
39. Ingman WV, Wyckoff J, Gouon-Evans V, Condeelis J, Pollard JW. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn 2006;235:3222-9.
40. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006;4:38.
41. Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, et al. Collagen density promotes mammary tumor initiation and progression. BMC Med 2008;6:11.
42. Sharpe CR, Collet JP, Belzile E, Hanley JA, Boivin JF. The effects of tricyclic antidepressants on breast cancer risk. Br JCancer 2002;86:92-7.
43. Roberts SB, Wozencraft CP, Coyne PJ, Smith TJ. Dexmedetomidine as an adjuvant analgesic for intractable cancer pain. J Palliat Med 2011;14:371-3.
44. Ugur F, Gulcu N, Boyaci A. Intrathecal infusion therapy with dexme-detomidine-supplemented morphine in cancer pain. Acta Anaesthesiol Scand 2007;51:388.
45. Powe DG, Entschladen F. Targeted therapies: using b-blockers to inhibit breast cancer progression. Nat Rev Clin Oncol 2011;8:511-2.